Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Association of COVID-19 Infections in San Francisco in Early March 2020 with Travel to New York and Europe

Wei Gu, Kevin Reyes, Elaine Hsu, Steve Miller, View ORCID ProfileCharles Chiu
doi: https://doi.org/10.1101/2020.04.04.20053629
Wei Gu
1Department of Laboratory Medicine, University of California, San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Reyes
1Department of Laboratory Medicine, University of California, San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Hsu
1Department of Laboratory Medicine, University of California, San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steve Miller
1Department of Laboratory Medicine, University of California, San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Chiu
1Department of Laboratory Medicine, University of California, San Francisco, California, USA
2UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charles Chiu
  • For correspondence: charles.chiu@ucsf.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Real-time dissemination of epidemiological survey data from positive COVID-19 cases is critical to support efforts to contain or reduce spread of viral infection in the community. Here we detected a significant association between domestic travel or travel to Europe and the identification of new cases in San Francisco, California, USA. These findings suggest that domestic and European travelers may need to be prioritized for evaluation of acute infection from COVID-19 in the setting of limited testing capacity.

As of April 4th, 2020, the COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus1 has infected more than 1.2 million people worldwide and the rise in cases has been exponential. In particular, New York cases in the United States surged from 22 to more than 113,000 between March 10 and now2, threatening to overwhelm hospitals and other regional health care systems in the city.

In San Francisco, we validated a qRT-PCR test to detect SARS-CoV-2 infection from nasopharyngeal swab samples based on the EUA (Emergency Use Authorization)- approved US CDC assay3. During the first 10 days since launch, we performed SARS-CoV-2 testing on 947 samples collected from March 10 through March 22 from patients with suspected SARS-CoV-2 infection at University of California, San Francisco. We analyzed the first 46 consecutive SARS-CoV-2 positive cases admitted to University of California, San Francisco hospitals or seen in outpatient clinics from March 10 through March 22. Data from these COVID-19 patients (Table 1) were matched with 102 randomly selected control patients over the same time period who tested negative for SARS-CoV-2. Documented history was recorded by a physician or nurse practitioner and included sick contacts, health care worker status, and travel history. Among the 46 COVID-19 patients, the median age was 44 years, 46% were female, and 65% were outpatients.

View this table:
  • View inline
  • View popup
Table 1. Clinical Characteristics of COVID-19 Positive Cases (n=46)

We noted that a travel history within 2 weeks of symptom onset (median date Mar 11, 2020) was significantly associated with COVID-19 infection (OR 3.8 [1.8-8.4]) (Figure 1). Out of the 20 travelers with COVID-19 infection, there were significant associations for prior travel to Europe (5 travelers, OR 6.1 [1.1-32.7]), USA (14 travelers, OR 4.0 [1.6-10.0]), and specifically New York (6 travelers, OR 32.9 [1.8-598]) as compared to 17 travelers without COVID-19 infection (Figure 2 and Table 2). No significant associations were found with regards to close contacts with known COVID-19 infected persons or frontline healthcare workers. Of note was one cluster of 3 positive cases associated with COVID-19 infection in an airport worker, that was categorized as a case of community rather than travel-associated transmission.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2. Risk Factor Associations with COVID-19 Infection
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 3. Travel Locations by Patient History
Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Associations with Positive COVID-19 RT-PCR Testing.

The odds ratios (OR) with 95% confidence intervals (CI) are displayed. Positives (n=46) were consecutive cases from March 10 to 20, 2020. Negatives (n=102) were randomized from the same time period. Significant risk factors (p <0.05) are designated with ‘*’ and were recent travel, including Europe, USA (domestic), and/or New York. Abbreviations: Pos, positive; Neg, negative; OR, odds ratio; CI, confidence interval.

Figure 2.
  • Download figure
  • Open in new tab
Figure 2. Travel History Associated with Positive Cases.

All positive cases and their associations are shown here (left). Cases that overlapped in two categories (e.g. traveler and contact with a known positive, n=3) and were counted as a half-case in each category. Those who did not have recent travel history, close contact with a known COVID-19 positive, or a frontline healthcare worker, were uniformly categorized as a community case. The most common association with a positive case was a travel history immediately prior to symptoms. Travelers (n=20) are subdivided by travel region (right).

Our evaluation of diagnosed COVID-19 cases in San Francisco in early March 2020 associates with travelers from New York prior to the recognized spike in New York cases in late March (Figure 3). Travel from New York was underrecognized as a risk factor for COVID-19 infection in the United States in early March. Guidelines for COVID-19 testing have not included screening for domestic travel. Our findings in San Francisco here can be extrapolated across America as there are over 100 direct domestic destinations and more than 6 million domestic flights a month from JFK, Newark, and LaGuardia airports4. In the near future, serological testing would be needed for surveillance of the much larger population of individuals with mild illness or asymptomatic infection5.

Figure 3.
  • Download figure
  • Open in new tab
Figure 3. Timeline of cumulative COVID-19 cases diagnosed in New York, and UCSF positive cases found in San Francisco in association with New York or Europe over time.

Each colored block represents a single patient.

Data Availability

De-identified data from UCSF patients is available upon

Funding

This work was funded by NIH grants R33-AI129455 (CYC) and K08-CA230156 (WG), the Charles and Helen Schwab Foundation (CYC), and a Burroughs-Wellcome CAMS Award (WG).

Competing Interests

CYC is the director of the UCSF-Abbott Viral Diagnostics and Discovery Center (VDDC) and receives research support funding from Abbott Laboratories. The other authors have declared no competing interest.

Ethics

The institutional review board at University of California, San Francisco approved this study. Non-identifying clinical, demographic, and laboratory data were extracted from the electronic medical board by retrospective chart review. Informed consent was waived for this minimal risk study.

Data Availability

De-identified data from UCSF patients is available upon request.

References

  1. 1.↵
    Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet 2020;395(10224):565–74.
    OpenUrl
  2. 2.↵
    New York Department of Health. County by county breakdown of positive cases. [Internet]. [accessed 2020 Mar 30];available from https://coronavirus.health.ny.gov/county-county-breakdown-positive-cases
  3. 3.↵
    US Centers for Disease Control and Prevention. Real-Time RT-PCR Panel for Detection 2019-nCoV. [Internet]. [accessed 2020 Mar 30]; available from https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html
  4. 4.↵
    Port Authority of New York and New Jersey Airport Traffic Statistics [Internet]. [accessed 2020 Mar 30];available from: https://www.panynj.gov/airports/en/statistics-general-info.html
  5. 5.↵
    Li R, Pei S, Chen B, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science 2020 [accessed 2020 Mar 30];Available from: https://science.sciencemag.org/content/early/2020/03/24/science.abb3221
Back to top
PreviousNext
Posted April 07, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Association of COVID-19 Infections in San Francisco in Early March 2020 with Travel to New York and Europe
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Association of COVID-19 Infections in San Francisco in Early March 2020 with Travel to New York and Europe
Wei Gu, Kevin Reyes, Elaine Hsu, Steve Miller, Charles Chiu
medRxiv 2020.04.04.20053629; doi: https://doi.org/10.1101/2020.04.04.20053629
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Association of COVID-19 Infections in San Francisco in Early March 2020 with Travel to New York and Europe
Wei Gu, Kevin Reyes, Elaine Hsu, Steve Miller, Charles Chiu
medRxiv 2020.04.04.20053629; doi: https://doi.org/10.1101/2020.04.04.20053629

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (199)
  • Anesthesia (54)
  • Cardiovascular Medicine (492)
  • Dentistry and Oral Medicine (90)
  • Dermatology (57)
  • Emergency Medicine (169)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (214)
  • Epidemiology (5718)
  • Forensic Medicine (3)
  • Gastroenterology (217)
  • Genetic and Genomic Medicine (871)
  • Geriatric Medicine (88)
  • Health Economics (232)
  • Health Informatics (767)
  • Health Policy (395)
  • Health Systems and Quality Improvement (254)
  • Hematology (105)
  • HIV/AIDS (185)
  • Infectious Diseases (except HIV/AIDS) (6522)
  • Intensive Care and Critical Care Medicine (393)
  • Medical Education (118)
  • Medical Ethics (28)
  • Nephrology (93)
  • Neurology (851)
  • Nursing (44)
  • Nutrition (142)
  • Obstetrics and Gynecology (164)
  • Occupational and Environmental Health (263)
  • Oncology (516)
  • Ophthalmology (164)
  • Orthopedics (44)
  • Otolaryngology (107)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (252)
  • Pharmacology and Therapeutics (147)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (980)
  • Public and Global Health (2249)
  • Radiology and Imaging (378)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (313)
  • Rheumatology (109)
  • Sexual and Reproductive Health (82)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)